Vitamin Cottage Natural Food Markets, Inc., a Lakewood, Colorado based natural grocery chain, is recalling multiple lots of Natural Grocers brand Organic Black Peppercorns as the product has the potential to be contaminated with Salmonella. Consumption of products containing Salmonella can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.
Category Archives: Food & Drug Recalls
FDA warns consumers not to use Zi Xiu Tang Bee Pollen capsules
The U.S. Food and Drug Administration is warning consumers to immediately stop using Zi Xiu Tang Bee Pollen, marketed as a product for weight loss and body reshaping. The product contains at least one potentially harmful active pharmaceutical ingredient that is not listed on the product’s label.
H Group, Inc. Issues Voluntary Allergen Alert on Undeclared Allergens in Caesar Salad with Caesar Dressing
H Group, Inc. of Framingham, MA is voluntarily recalling 509 units of Trader Giotto’s Caesar Salad with Caesar Dressing (SKU 05161) sold in the refrigeration section. These 509 individual salads are marked with the following date codes: “Sell By 04/6/14, 04/7/14 and 04/8/14.”
Frontier Natural Products Co-op Initiates Voluntary Class 1 Recall Due to Possible Health Risk from Organic Black Peppercorns
Frontier Natural Products Co-op is voluntarily recalling several of its products manufactured with organic black peppercorns that were sold under its Frontier and Simply Organic brands, Whole Foods Market 365 Everyday Value, and others due to potential Salmonella contamination. To date, no illnesses have been associated with these products.
Sprouts Farmers Market Recalls Organic Black Peppercorns Due to Possible Health Risk
Sprouts Farmers Market, Inc. (the “Company”) is recalling Organic Black Peppercorns sold under the Sprouts brand name from all stores. This product has the potential to be contaminated with Salmonella, an organism that can cause serious and sometimes fatal infections in young children, the elderly, and others with weakened immune systems.
Whole Foods Market’s Northern California Region Recalls Chipotle Chicken Wraps Due to Undeclared Fish Allergen
Whole Foods Market’s Northern California region is recalling its Chipotle Chicken Wrap because it contains an undeclared allergen. The wrap, labeled as “Chipotle Chicken Wrap,” is filled with a Chicken Caesar wrap mix, which contains a fish allergen (anchovies) not declared on the Chipotle Chicken Wrap label.
FDA approves new hand-held auto-injector to reverse opioid overdose
The U.S. Food and Drug Administration today approved a prescription treatment that can be used by family or caregivers to treat a person known or suspected to have had an opioid overdose. Evzio (naloxone hydrochloride injection) rapidly delivers a single dose of the drug naloxone via a hand-held auto-injector that can be carried in a pocket or stored in a medicine chest.
FDA Commissioner Margaret A. Hamburg Statement on Prescription Opioid Abuse
For more than a decade, the U.S. Food and Drug Administration has been working to address the important public health problems associated with the misuse, abuse, addiction and overdose of opioid analgesics, while at the same time working to ensure continued access to effective and appropriate medications for millions of Americans currently suffering from pain. I firmly believe that these goals are compatible, and that actions to address one should not be at the expense of the other.
Proposed health IT strategy aims to promote innovation, protect patients, and avoid regulatory duplication
The U.S. Department of Health and Human Services (HHS) today released a draft report that includes a proposed strategy and recommendations for a risk-based regulatory framework for health information technology (health IT) that promotes product innovation while maintaining appropriate patient protections and avoiding regulatory duplication. The congressionally-mandated report proposes to clarify federal regulatory oversight of health IT products based on a product’s function and the potential risk to patients who use it.
FDA allows marketing for first-of-kind dressing to control bleeding from certain battlefield wounds
Today, the U.S. Food and Drug Administration allowed marketing of an expandable, multi-sponge wound dressing to control the bleeding from certain types of wounds received in battle. For military use only, the XSTAT is a temporary dressing for wounds in areas that a tourniquet cannot be placed, such as the groin or armpit. The dressing can be used up to four hours, which could allow time for the patient to receive surgical care.